Bridgeway Capital Management, LLC Trevena Inc Transaction History

Bridgeway Capital Management, LLC

  • $4.76 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$2.13 - $3.26 $223,650 - $342,300
-105,000 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$1.53 - $3.13 $153,000 - $313,000
-100,000 Reduced 48.78%
105,000 $314,000
Q2 2019

Aug 14, 2019
BUY
$0.94 - $1.6 $192,700 - $328,000
205,000 New
205,000 $211,000

About TREVENA INC

TRVN Quotes by TradingView
  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $38.2M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email